These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15253079)

  • 1. Polymyxin B protects horses against induced endotoxaemia in vivo.
    Barton MH; Parviainen A; Norton N
    Equine Vet J; 2004 Jul; 36(5):397-401. PubMed ID: 15253079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses.
    Parviainen AK; Barton MH; Norton NN
    Am J Vet Res; 2001 Jan; 62(1):72-6. PubMed ID: 11197565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia.
    MacKay RJ; Clark CK; Logdberg L; Lake P
    Am J Vet Res; 1999 Jan; 60(1):68-75. PubMed ID: 9918150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of dimethyl sulphoxide effects on initial response to endotoxin in the horse.
    Kelmer G; Doherty TJ; Elliott S; Saxton A; Fry MM; Andrews FM
    Equine Vet J; 2008 Jun; 40(4):358-63. PubMed ID: 18356128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the anti-endotoxin effects of polymyxin B in a feline model of endotoxemia.
    Sharp CR; DeClue AE; Haak CE; Honaker AR; Reinero CR
    J Feline Med Surg; 2010 Apr; 12(4):278-85. PubMed ID: 20156699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses.
    Moore JN; Norton N; Barton MH; Hurley DJ; Reber AJ; Donovan DC; Vandenplas ML; Parker TS; Levine DM
    Equine Vet J; 2007 May; 39(3):243-8. PubMed ID: 17520976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous administration of polymyxin B in neonatal foals with experimental endotoxemia.
    Wong DM; Sponseller BA; Alcott CJ; Agbedanu PN; Wang C; Hsu WH
    J Am Vet Med Assoc; 2013 Sep; 243(6):874-81. PubMed ID: 24004237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of early-phase endotoxin tolerance in horses.
    Allen GK; Campbell-Beggs C; Robinson JA; Johnson PJ; Green EM
    Equine Vet J; 1996 Jul; 28(4):269-74. PubMed ID: 8818592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of a phospholipid emulsion on the initial response of horses administered endotoxin.
    Winchell WW; Hardy J; Levine DM; Parker TS; Gordon BR; Saal SD
    Am J Vet Res; 2002 Oct; 63(10):1370-8. PubMed ID: 12371762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
    Barton MH; Moore JN; Norton N
    Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
    Baskett A; Barton MH; Norton N; Anders B; Moore JN
    Am J Vet Res; 1997 Nov; 58(11):1291-9. PubMed ID: 9361895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of eltenac in horses with induced endotoxaemia.
    MacKay RJ; Daniels CA; Bleyaert HF; Bailey JE; Gillis KD; Merritt AM; Katz TL; Johnson JC; Thompson KC
    Equine Vet J Suppl; 2000 Jun; (32):26-31. PubMed ID: 11202378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral clenbuterol on the clinical and inflammatory response to endotoxaemia in the horse.
    Cudmore LA; Muurlink T; Whittem T; Bailey SR
    Res Vet Sci; 2013 Jun; 94(3):682-6. PubMed ID: 23462621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin.
    Bueno AC; Seahorn TL; Cornick-Seahorn J; Horohov DW; Moore RM
    Am J Vet Res; 1999 Aug; 60(8):969-76. PubMed ID: 10451207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
    Carrick JB; Morris DD; Moore JN
    Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia.
    Poulin Braim AE; MacDonald MH; Bruss ML; Grattendick KJ; Giri SN; Margolin SB
    Am J Vet Res; 2009 Aug; 70(8):1031-42. PubMed ID: 19645586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunomodulating effects of ketamine in horses with experimental endotoxemia.
    Alcott CJ; Sponseller BA; Wong DM; Davis JL; Soliman AM; Wang C; Hsu W
    J Vet Intern Med; 2011; 25(4):934-43. PubMed ID: 21745244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of endotoxaemia and septicaemia in the equine patient.
    Werners AH
    J Vet Pharmacol Ther; 2017 Jan; 40(1):1-15. PubMed ID: 27452161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously.
    Durando MM; MacKay RJ; Linda S; Skelley LA
    Am J Vet Res; 1994 Jul; 55(7):921-7. PubMed ID: 7978630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl pyruvate diminishes the inflammatory response to lipopolysaccharide infusion in horses.
    Jacobs CC; Holcombe SJ; Cook VL; Gandy JC; Hauptman JG; Sordillo LM
    Equine Vet J; 2013 May; 45(3):333-9. PubMed ID: 22943507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.